British Journal of Cancer - Table of Contents alert Volume 109 Issue 8

TABLE OF CONTENTS Volume 109, Issue 8 (2027-2294) Published online 15 October 2013 In this issue Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Clinical Studies Top Emergency presentation of cancer and short-term mortality S McPhail, L Elliss-Brookes, J Shelton, A Ives, M Greenslade, S Vernon, E J A Morris and M Richards Br J Cancer 2013 109: 2027-2034; advance online publication, September 17, 2013; 10.1038/bjc.2013.569 Abstract | Full Text Quantifying the natural history of breast cancer K H X Tan, L Simonella, H L Wee, A Roellin, Y-W Lim, W-Y Lim, K S Chia, M Hartman and A R Cook Br J Cancer 2013 109: 2035-2043; advance online publication, October 1, 2013; 10.1038/bjc.2013.471 Abstract | Full Text Re-attendance after false-positive screening mammography: a population-based study in the Netherlands W Setz-Pels, L E M Duijm, J W Coebergh, M Rutten, J Nederend and A C Voogd Br J Cancer 2013 109: 2044-2050; advance online publication, September 19, 2013; 10.1038/bjc.2013.573 Abstract | Full Text Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2 years (2009–2010) E Liniker, M Harrison, J M J Weaver, N Agrawal, A Chhabra, V Kingshott, S Bailey, T G G Eisen and P G Corrie Br J Cancer 2013 109: 2051-2057; advance online publication, September 24, 2013; 10.1038/bjc.2013.495 Abstract | Full Text Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit A Khakwani, A L Rich, H A Powell, L J Tata, R A Stanley, D R Baldwin, J P Duffy and R B Hubbard Br J Cancer 2013 109: 2058-2065; advance online publication, September 19, 2013; 10.1038/bjc.2013.572 Abstract | Full Text Montreal prognostic score: estimating survival of patients with non-small cell lung cancer using clinical biomarkers B Gagnon, J S Agulnik, I Gioulbasanis, G Kasymjanova, D Morris and N MacDonald Br J Cancer 2013 109: 2066-2071; advance online publication, September 24, 2013; 10.1038/bjc.2013.515 Abstract | Full Text Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma K Miyahara, K Nouso, Y Morimoto, Y Takeuchi, H Hagihara, K Kuwaki, H Onishi, F Ikeda, Y Miyake, S Nakamura, H Shiraha, A Takaki, M Honda, S Kaneko, T Sato, S Sato, S Obi, S Iwadou, Y Kobayashi, K Takaguchi, K Kariyama, Y Takuma, H Takabatake, K Yamamoto and for the Okayama Liver Cancer Group:  Kazuhide Yamamoto, Yuki Morimoro, Yasuto Takeuchi, Koji Miyahara, Hiroaki Hagihara, Kenji Kuwaki, Hideki Onishi, Shinichiro Nakamura, Hidenori Shiraha, Kazuhiro Nouso, Yoshitaka Takuma, Hiroyuki Takabatake, Youichi Morimoto, Shin-ichi Fujioka, Toshiya Osawa, Kazuya Kariyama, Junichi Toshimori, Haruhiko Kobashi, Hirokazu Miyatake, Shouta Iwadou, Yoshiyuki Kobayashi, Shuji Uematsu, Ryoichi Okamoto, Yasuyuki Araki, Masafumi Tatsukawa, Kazuhisa Yabushita, Toshinari Shimoe, Kohsaku Sakaguchi, Tatsuro Sakata, Toshihiko Kaneyoshi, Manabi Miyashita, Yasuhiro Makino, Akio Moriya, Masaharu Ando, Nobuyuki Baba, Tomonori Seno, Takuya Nagano, Koichi Takaguchi, Eiji Matsumoto and Hiroki Takayama Br J Cancer 2013 109: 2072-2078; advance online publication, September 17, 2013; 10.1038/bjc.2013.554 Abstract | Full Text Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer W Koizumi, K Yamaguchi, H Hosaka, Y Takinishi, N Nakayama, T Hara, K Muro, H Baba, Y Sasaki, T Nishina, N Fuse, T Esaki, M Takagi, M Gotoh and T Sasaki Br J Cancer 2013 109: 2079-2086; advance online publication, September 17, 2013; 10.1038/bjc.2013.555 Abstract | Full Text Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research S G Patel, M Amit, T C Yen, C T Liao, P Chaturvedi, J P Agarwal, L P Kowalski, A Ebrahimi, J R Clark, C R Cernea, S J Brandao, M Kreppel, J Zöller, D Fliss, E Fridman, G Bachar, T Shpitzer, V A Bolzoni, P R Patel, S Jonnalagadda, K T Robbins, J P Shah and Z Gil for The International Consortium for Outcome Research (ICOR) in Head and Neck Cancer Br J Cancer 2013 109: 2087-2095; advance online publication, September 24, 2013; 10.1038/bjc.2013.570 Abstract | Full Text ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial J E Bauman, M C Austin, R Schmidt, B F Kurland, A Vaezi, D N Hayes, E Mendez, U Parvathaneni, X Chai, S Sampath and R G Martins Br J Cancer 2013 109: 2096-2105; advance online publication, September 24, 2013; 10.1038/bjc.2013.576 Abstract | Full Text Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy L Lima, P F Severino, M Silva, A Miranda, A Tavares, S Pereira, E Fernandes, R Cruz, T Amaro, C A Reis, F Dall'Olio, F Amado, P A Videira, L Santos and J A Ferreira Br J Cancer 2013 109: 2106-2114; advance online publication, September 24, 2013; 10.1038/bjc.2013.571 Abstract | Full Text Changing presentation of prostate cancer in a UK population – 10 year trends in prostate cancer risk profiles in the East of England D C Greenberg, K A Wright, A Lophathanon, K R Muir and V J Gnanapragasam Br J Cancer 2013 109: 2115-2120; advance online publication, September 26, 2013; 10.1038/bjc.2013.589 Abstract | Full Text The impact of supportive nursing care on the needs of men with prostate cancer: a study across seven European countries J Cockle-Hearne, F Charnay-Sonnek, L Denis, H E Fairbanks, D Kelly, S Kav, K Leonard, E van Muilekom, P Fernandez-Ortega, B T Jensen and S Faithfull Br J Cancer 2013 109: 2121-2130; advance online publication, September 24, 2013; 10.1038/bjc.2013.568 Abstract | Full Text Translational Therapeutics Top The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance A P Toner, F McLaughlin, F J Giles, F J Sullivan, E O'Connell, L A Carleton, L Breen, G Dunne, A M Gorman, J D Lewis and S A Glynn Br J Cancer 2013 109: 2131-2141; advance online publication, September 19, 2013; 10.1038/bjc.2013.537 Abstract | Full Text Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery J PosthumaDeBoer, S R Piersma, T V Pham, P W van Egmond, J C Knol, A M Cleton-Jansen, M A van Geer, V W van Beusechem, G J L Kaspers, B J van Royen, C R Jiménez and M N Helder Br J Cancer 2013 109: 2142-2154; advance online publication, September 24, 2013; 10.1038/bjc.2013.578 Abstract | Full Text EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy T Kumai, Y Matsuda, K Oikawa, N Aoki, S Kimura, Y Harabuchi, E Celis and H Kobayashi Br J Cancer 2013 109: 2155-2166; advance online publication, September 17, 2013; 10.1038/bjc.2013.577 Abstract | Full Text Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen E Reginato, P Mroz, H Chung, M Kawakubo, P Wolf and M R Hamblin Br J Cancer 2013 109: 2167-2174; advance online publication, September 24, 2013; 10.1038/bjc.2013.580 Abstract | Full Text γ-Glutamyl hydrolase modulation and folate influence chemosensitivity of cancer cells to 5-fluorouracil and methotrexate S-E Kim, P D Cole, R C Cho, A Ly, L Ishiguro, K-J Sohn, R Croxford, B A Kamen and Y-I Kim Br J Cancer 2013 109: 2175-2188; advance online publication, September 17, 2013; 10.1038/bjc.2013.579 Abstract | Full Text Molecular Diagnostics Top MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways X-J Li, X-Q Luo, B-W Han, F-T Duan, P-P Wei and Y-Q Chen Br J Cancer 2013 109: 2189-2198; advance online publication, September 12, 2013; 10.1038/bjc.2013.562 Abstract | Full Text PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression R Uchi, R Kogo, K Kawahara, T Sudo, T Yokobori, H Eguchi, K Sugimachi, T Maehama, M Mori, A Suzuki, S Komune and K Mimori Br J Cancer 2013 109: 2199-2206; advance online publication, September 17, 2013; 10.1038/bjc.2013.561 Abstract | Full Text The in situ local immune response, tumour senescence and proliferation in colorectal cancer C S Roxburgh, C H Richards, A I MacDonald, A G Powell, L M McGlynn, D C McMillan, P G Horgan, J Edwards and P G Shiels Br J Cancer 2013 109: 2207-2216; advance online publication, September 10, 2013; 10.1038/bjc.2013.556 Abstract | Full Text Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis V S Warneke, H-M Behrens, J Haag, S Krüger, E Simon, M Mathiak, M P A Ebert and C Röcken Br J Cancer 2013 109: 2217-2227; advance online publication, September 5, 2013; 10.1038/bjc.2013.536 Abstract | Full Text Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes S U Lauvrak, E Munthe, S H Kresse, E W Stratford, H M Namløs, L A Meza-Zepeda and O Myklebost Br J Cancer 2013 109: 2228-2236; advance online publication, September 24, 2013; 10.1038/bjc.2013.549 Abstract | Full Text Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis T Osawa, N Ohga, K Akiyama, Y Hida, K Kitayama, T Kawamoto, K Yamamoto, N Maishi, M Kondoh, Y Onodera, M Fujie, N Shinohara, K Nonomura, M Shindoh and K Hida Br J Cancer 2013 109: 2237-2247; advance online publication, September 17, 2013; 10.1038/bjc.2013.535 Abstract | Full Text The FGFR1 inhibitor PD173074 induces mesenchymal–epithelial transition through the transcription factor AP-1 P T Nguyen, T Tsunematsu, S Yanagisawa, Y Kudo, M Miyauchi, N Kamata and T Takata Br J Cancer 2013 109: 2248-2258; advance online publication, September 17, 2013; 10.1038/bjc.2013.550 Abstract | Full Text Spindle cell morphology is related to poor prognosis in vulvar squamous cell carcinoma M D Trietsch, A A W Peters, K N Gaarenstroom, S H L van Koningsbrugge, N T ter Haar, E M Osse, N Halbesma and G J Fleuren Br J Cancer 2013 109: 2259-2265; advance online publication, September 24, 2013; 10.1038/bjc.2013.563 Abstract | Full Text Genetics and Genomics Top Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma X Li, Z Wu, Q Mei, X Li, M Guo, X Fu and W Han Br J Cancer 2013 109: 2266-2278; advance online publication, September 10, 2013; 10.1038/bjc.2013.548 Abstract | Full Text The clinical implication of SS18-SSX fusion gene in synovial sarcoma T Ren, Q Lu, W Guo, Z Lou, X Peng, G Jiao and Y Sun Br J Cancer 2013 109: 2279-2285; advance online publication, September 10, 2013; 10.1038/bjc.2013.547 Abstract | Full Text Iodine-131 dose-dependent gene expression: alterations in both normal and tumour thyroid tissues of post-Chernobyl thyroid cancers M Abend, R M Pfeiffer, C Ruf, M Hatch, T I Bogdanova, M D Tronko, J Hartmann, V Meineke, K Mabuchi and A V Brenner Br J Cancer 2013 109: 2286-2294; advance online publication, September 17, 2013; 10.1038/bjc.2013.574 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.